Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Revenue	6.08B	5.85B	5.80B
United States Revenue Growth	3.93%	0.83%	0.57%
Emerging Markets Revenue	1.35B	1.35B	1.34B
Emerging Markets Revenue Growth	-0.37%	0.52%	7.18%
Rest of World Revenue	3.60B	3.44B	3.22B
Rest of World Revenue Growth	4.71%	6.87%	5.93%
Revenue (Total)	11.02B	10.64B	10.36B
Revenue (Total) Growth	3.64%	2.66%	3.01%

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Infusion Therapies Revenue	4.06B	4.10B	3.96B
Infusion Therapies Revenue Growth	-0.97%	3.61%	3.75%
Advanced Surgery Revenue	1.16B	1.10B	1.05B
Advanced Surgery Revenue Growth	5.25%	5.04%	5.31%
Medical Products & Therapies Revenue	5.23B	5.21B	5.01B
Medical Products & Therapies Revenue Growth	0.35%	3.91%	4.07%
Care & Connectivity Solutions Revenue	1.88B	1.81B	1.80B
Care & Connectivity Solutions Revenue Growth	3.53%	0.78%	0.50%
Front Line Care Revenue	1.15B	1.14B	1.21B
Front Line Care Revenue Growth	1.14%	-6.26%	5.66%
Healthcare Systems & Technologies Revenue	3.03B	2.95B	3.01B
Healthcare Systems & Technologies Revenue Growth	2.61%	-2.06%	2.52%
Injectables and Anesthesia Revenue	1.38B	1.37B	1.35B
Injectables and Anesthesia Revenue Growth	0.73%	1.93%	3.22%
Drug Compounding Revenue	1.09B	1.04B	902.00M
Drug Compounding Revenue Growth	4.53%	15.08%	9.87%
Pharmaceuticals Revenue	2.47B	2.41B	2.25B
Pharmaceuticals Revenue Growth	2.36%	7.20%	5.79%
Other Revenue (Post-Q2 2023 Reporting)	302.00M	67.00M	87.00M
Other Revenue (Post-Q2 2023 Reporting) Growth	350.75%	-22.99%	-50.85%
Revenue (Total)	11.02B	10.64B	10.36B
Revenue (Total) Growth	3.64%	2.66%	3.01%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Medical Products & Therapies Operating Income	973.00M	950.00M	972.00M
Medical Products & Therapies Operating Income Growth	2.42%	-2.26%	1.04%
Healthcare Systems & Technologies Operating Income	460.00M	468.00M	483.00M
Healthcare Systems & Technologies Operating Income Growth	-1.71%	-3.11%	-2.23%
Pharmaceuticals Operating Income	285.00M	313.00M	401.00M
Pharmaceuticals Operating Income Growth	-8.95%	-21.95%	2.56%
Other Operating Income	23.00M	18.00M	18.00M
Other Operating Income Growth	27.78%	-	-76.62%
Operating Income (Total)	411.00M	14.00M	707.00M
Operating Income (Total) Growth	2835.71%	-98.02%	-

Updated Sep 30, 2025. Data Source: Fiscal.ai.